ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SNWV vs TELA // OPERATING MARGIN

SANUWAVE Health Inc. (NASDAQ) VS. TELA Bio Inc. (NASDAQ) • 15-METRIC TALLY: SNWV 8 — TELA 0
▲ OPERATING MARGIN LEADER: SNWV
operating-margins
11.20%
operating-margins
-42.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SNWV VS. TELA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SNWV TELA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 77.10% 67.70% +9.40 SNWV /gross-margins <GO>
Return on Invested Capital (ROIC) 67.30% -35.00% +102.30 SNWV /roic <GO>
EV/EBITDA & P/E Valuation 7.5x — — TIE /valuation <GO>
Free Cash Flow Yield 4.27% — — TIE /fcf-yield <GO>
Operating Margin ACTIVE 11.20% -42.00% +53.20 SNWV /operating-margins <GO>
Net Profit Margin 26.80% -48.30% +75.10 SNWV /net-margins <GO>
Revenue Growth (YoY) 36.30% 15.80% +20.50 SNWV /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 7/9 4/9 +3.00 SNWV /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 53.1 43.6 +9.50 SNWV /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 3.5x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $45.3M $41.5M $3.8M SNWV /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SNWV REV TELA REV SNWV GROSS % TELA GROSS % SNWV FCF TELA FCF
FY 2025 $44.1M $80.3M 77.1% 67.7% $1.9M -$28.7M
FY 2024 $32.3M $69.3M 75.9% 67.1% $2.0M -$42.6M
FY 2023 $19.3M $58.5M — — -$4.5M -$40.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SNWV // BETA —
TELA // BETA —